CA Stock MarketDetailed Quotes
WBIO WPD Pharmaceuticals Inc
- 0.010
- -0.005-33.33%
15min DelayMarket Closed Jul 5 12:29 ET
1.15MMarket Cap0.00P/E (TTM)
0.010High0.010Low30.00KVolume0.010Open0.015Pre Close300.00Turnover0.03552wk High0.03%Turnover Ratio114.82MShares0.00552wk Low--EPS TTM1.12MFloat Cap2.250Historical High0.33P/E (Static)111.97MShs Float0.005Historical Low0.03EPS LYR0.00%Amplitude--Dividend TTM-1.67P/B1Lot Size--Div YieldTTM
WPD Pharmaceuticals Inc Key Stats
Quarterly+Annual
YOY
| (Q1)Mar 31, 2024 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | (Q3)Sep 30, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -261.09%-75.02K | 98.74%-45.64K | -103.69%-81.09K | 98.36%-20.78K | -3.43M | -742.29K | -2,413.96%-3.62M | 2,099.75%2.2M | -695.56%-1.27M | -119.30%-143.84K |
| Net income from continuing operations | -315.11%-157.62K | 97.68%-85.85K | -104.02%-78.65K | 93.36%-37.97K | --3.86M | --6.17M | -422.28%-3.7M | 259.68%1.96M | 50.54%-571.63K | 43.92%-707.63K |
| Operating gains losses | ---- | ---- | ---- | ---- | ---4.52M | ---- | ---- | ---- | ---- | ---- |
| Depreciation and amortization | --2.71K | -58.87%3.51K | --0 | --0 | --24.44K | --6.24K | -90.56%8.53K | -93.84%5.54K | -95.46%4.13K | 257.85%90.39K |
| Asset impairment expenditure | ---- | --0 | ---- | ---- | --30.1K | --11.83K | ---3.11K | --21.01K | --365 | ---- |
| Unrealized gains and losses of investment securities | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---- |
| Remuneration paid in stock | ---- | --0 | ---- | ---- | --44.18K | --5.78K | -58.89%8.66K | -58.89%8.66K | -78.03%21.08K | -97.24%21.07K |
| Other non cashItems | --15.37K | -99.37%17.83K | ---- | ---- | --167.52K | --30.15K | 117,116.93%2.82M | -306,391.77%-2.72M | 809.48%36.28K | 385.66%2.4K |
| Change In working capital | 275.24%64.52K | 8.09%18.88K | -104.90%-7.43K | 102.27%17.19K | ---3.03M | ---2.44M | -96.12%17.46K | -84.90%151.56K | -194.00%-757.15K | -63.06%449.93K |
| -Change in receivables | -222.72%-4.82K | 95.91%-3.57K | 97.38%-2.38K | 98.69%-1.49K | ---60.41K | --232.12K | 10.52%-87.15K | -130.91%-91.16K | 64.21%-114.22K | -996.33%-97.4K |
| -Change in prepaid assets | ---- | -344.83%-11K | ---- | ---- | --35K | ---636 | --4.49K | --1.03K | --30.12K | ---- |
| -Change in payables and accrued expense | 271.05%69.33K | -80.97%33.44K | -101.52%-5.04K | 102.21%18.69K | ---1.44M | ---1.11M | -80.04%175.7K | 71.72%331.69K | -175.05%-843.97K | -27.10%880.07K |
| -Change in other working capital | ---- | ---- | ---- | ---- | ---1.56M | ---1.57M | 77.29%-75.58K | ---90K | --170.92K | ---332.74K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -261.09%-75.02K | 94.61%-45.64K | 85.86%-81.09K | 98.36%-20.78K | ---3.43M | ---742.29K | -488.44%-846.38K | -422.35%-573.61K | -695.56%-1.27M | -119.30%-143.84K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | -239.05K | -216.65K | 0 | -162.36%-22.04K | 99.12%-365 | 142.10%9.51K | |||
| Net PPE purchase and sale | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -119.41%-292 |
| Net intangibles purchas and sale | ---- | --0 | ---- | ---- | ---36.35K | ---13.95K | --0 | -162.36%-22.04K | 99.12%-365 | 140.68%9.8K |
| Net business purchase and sale | ---- | ---- | ---- | ---- | ---202.71K | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | ---- | --0 | ---- | ---- | ---239.05K | ---216.65K | --0 | -162.36%-22.04K | 99.12%-365 | 142.10%9.51K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -657.44%-32.84K | 1.23M | 500.98K | -101.96%-4.34K | 12,488.66%244.8K | 24,002.32%484.02K | 1,758.26%221.26K | |||
| Net issuance payments of debt | ---- | --0 | ---- | ---- | --722.09K | ---2.4K | -101.96%-4.34K | 12,488.66%244.8K | 24,002.32%484.02K | 1,757.01%221.26K |
| Net other financing activities | ---- | ---- | ---- | ---- | --503.37K | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | ---- | -657.44%-32.84K | ---- | ---- | --1.23M | --500.98K | -101.96%-4.34K | 12,488.66%244.8K | 24,002.32%484.02K | 1,757.01%221.26K |
| Net cash flow | ||||||||||
| Beginning cash position | 260.85%85.86K | -70.84%221.93K | -97.44%23.02K | -98.61%23.79K | --1.71M | --196.96K | -53.42%761.17K | -46.51%897.66K | -8.57%1.71M | -17.90%1.63M |
| Current changes in cash | -9,567.65%-75.02K | 90.78%-78.47K | 156.70%198.91K | 99.90%-776 | ---2.44M | ---457.96K | -1,078.60%-850.72K | -191.91%-350.85K | -286.06%-783.27K | -87.74%86.93K |
| Effect of exchange rate changes | ---- | --0 | ---- | ---- | --757.92K | --284.8K | 205.83%286.51K | 182.07%214.35K | -324.08%-27.75K | ---270.73K |
| End cash Position | -52.91%10.84K | -27.16%143.46K | -70.84%221.93K | -97.44%23.02K | --23.79K | --23.79K | -86.42%196.96K | -53.42%761.17K | -46.51%897.66K | -46.28%1.45M |
| Free cash from | -261.09%-75.02K | 94.61%-45.64K | 86.39%-81.09K | 98.36%-20.78K | ---3.47M | ---756.23K | -530.08%-846.38K | -403.88%-595.65K | -530.92%-1.27M | -118.59%-134.33K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Latest Price
%Chg